top of page
MISSION
The Pharmacy Addictions Research & Medicine (PhARM) Program addresses systemic barriers, inequities, and stigma related to evidence-based substance use disorder treatment and harm reduction interventions by conducting innovative research and providing education and resources informed by people with lived experience to health professionals, paraprofessionals, academics, and community members.
educational programs
Meet The Team
FACULTY & STAFF
Tyler Varisco, PharmD, PhD
Director
Lindsey Loera, PharmD
Associate Director
.jpeg)
Jennifer Bosworth, PharmD
Associate Director
Jenny Carrasco, MA
Program & Communications Manager
Mona Keshavarzi, BA
Research Program Coordinator
Kiyoung Kim, PhD, MPH
Data Analyst
Sophia Rhoades, MSc
Implementation Associate
Daniel Sledge, LP
Academic Detailer
Affiliate members
Samantha Catanzano, PharmD, BCPP
Affiliate Faculty
Carlos Tirado, MD, MPH
Medical Consultant
Deepika Rao, PhD
Affiliate Faculty
_edited.jpg)
Claire Zagorski, MSc, LP
Affiliate Member
TRAINEES
Brittany Herman
Research Assistant
Marissa Johnson
Research Assistant
Parasto Mousavi, PharmD
Graduate Research Assistant
Edwin Rice
Research Assistant
Abolfazl Sadeghi, PharmD, HTA, MSc
Graduate Research Assistant
Gavin Sarabia
Marketing Student Assistant
HomeTop
We're pleased to share that Dr. Tyler Varisco has officially joined us as the new Director of the PhARM Program!
Dr. Varisco is a registered pharmacist and trained health services researcher whose work focuses on improving the quality of care for people with a substance use disorder. He earned his Doctor of Pharmacy from The University of Texas at Austin College of Pharmacy and his Ph.D. in Pharmaceutical Health Outcomes and Policy from the University of Houston College of Pharmacy.
Throughout his career, Dr. Varisco has led impactful, collaborative efforts to expand access to treatment. He played a key role in developing the Pharmacy Access to Resources and Medication for OUD Practice Guideline, and currently serves as a subject matter expert for SAMHSA’s revision of Treatment Improvement Protocol 63, which guides the use of medications for opioid use disorder across the country. His research continues to shape how policy influences both patient and provider experiences in behavioral health and addiction care.
We’re excited to welcome Dr. Varisco into this leadership role and look forward to the expertise and vision he brings to the PhARM Program.
Leading the Way Forward: Meet Our New Director
bottom of page